Prenetics Global Limited
PRE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $185 | $113 | $51 | $74 |
| - Cash | $13 | $17 | $48 | $52 |
| + Debt | $2 | $3 | $5 | $6 |
| Enterprise Value | $174 | $98 | $8 | $27 |
| Revenue | $24 | $18 | $17 | $10 |
| % Growth | 33.2% | 2.1% | 65.1% | – |
| Gross Profit | $14 | $7 | $7 | $4 |
| % Margin | 59.5% | 41.2% | 42.4% | 37.2% |
| EBITDA | -$7 | -$11 | -$11 | -$25 |
| % Margin | -28.5% | -61.6% | -63.6% | -237.3% |
| Net Income | -$7 | -$12 | -$10 | -$16 |
| % Margin | -31.4% | -70.2% | -60% | -155.8% |
| EPS Diluted | -0.53 | -0.94 | -0.8 | -1.29 |
| % Growth | 43.6% | -17.5% | 38% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |